TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors June 29, 2001
TCL Archive Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research August 3, 2012
